CANCER IMMUNOTHERAPY INDEX
News Releases
12/20/2022 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
06/20/2022 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
12/21/2021 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
11/17/2021 - LCINDX Announces Merger Replacement
11/5/2021 - Action Relating to bluebird bio's spin-off of 2seventy bio
06/15/2021 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
12/15/2020 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
06/16/2020 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
12/17/2019 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
06/18/2019 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
12/18/2018 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
6/20/2018 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
3/1/2018 - LCINDX Announces Merger Replacement
12/21/2017 - Discussing Immunotherapy on The Bio Report Podcast
12/20/2017 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
10/4/2017 - LCINDX Announces Merger Replacements
9/1/2017 - Discussing CAR-T on Zacks Friday Finish Line Podcast
6/21/2017 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
12/21/2016 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
8/17/2016 - Loncar Index Sponsors Episode of Novel Targets Podcast
6/21/2016 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
12/16/2015 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
6/17/2015 - LCINDX Semi-Annual Rebalance/Reconstitution Notice
4/7/2015 - Loncar Investments Launches Cancer Immunotherapy Index